121 related articles for article (PubMed ID: 9764403)
1. Clinical effects of the recombinant feline interferon-omega on experimental parvovirus infection in beagle dogs.
Ishiwata K; Minagawa T; Kajimoto T
J Vet Med Sci; 1998 Aug; 60(8):911-7. PubMed ID: 9764403
[TBL] [Abstract][Full Text] [Related]
2. Feline interferon-omega treatment on canine parvovirus infection.
Minagawa T; Ishiwata K; Kajimoto T
Vet Microbiol; 1999 Sep; 69(1-2):51-3. PubMed ID: 10515269
[TBL] [Abstract][Full Text] [Related]
3. Treatment of canine parvoviral enteritis with interferon-omega in a placebo-controlled challenge trial.
Martin V; Najbar W; Gueguen S; Grousson D; Eun HM; Lebreux B; Aubert A
Vet Microbiol; 2002 Oct; 89(2-3):115-27. PubMed ID: 12243889
[TBL] [Abstract][Full Text] [Related]
4. Immunological effects of recombinant feline interferon-omega (KT-80) administration in the dog.
Kuwabara M; Nariai Y; Horiuchi Y; Nakajima Y; Yamaguchi Y; Horioka E; Kawanabe M; Kubo T; Yukawa M; Sakai T
Microbiol Immunol; 2006; 50(8):637-41. PubMed ID: 16924149
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of inflammation and immunity in cats with spontaneous parvovirus infection: consequences of recombinant feline interferon-omega administration.
Paltrinieri S; Crippa A; Comerio T; Angioletti A; Roccabianca P
Vet Immunol Immunopathol; 2007 Jul; 118(1-2):68-74. PubMed ID: 17521745
[TBL] [Abstract][Full Text] [Related]
6. Oral and subcutaneous therapy of canine atopic dermatitis with recombinant feline interferon omega.
Litzlbauer P; Weber K; Mueller RS
Cytokine; 2014 Mar; 66(1):54-9. PubMed ID: 24548425
[TBL] [Abstract][Full Text] [Related]
7. Oral Recombinant Feline Interferon-Omega as an alternative immune modulation therapy in FIV positive cats: clinical and laboratory evaluation.
Gil S; Leal RO; McGahie D; Sepúlveda N; Duarte A; Niza MM; Tavares L
Res Vet Sci; 2014 Feb; 96(1):79-85. PubMed ID: 24332273
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and molecular epidemiology of Canine parvovirus 2 in diarrheic dogs in Colombia, South America: A possible new CPV-2a is emerging?
Duque-García Y; Echeverri-Zuluaga M; Trejos-Suarez J; Ruiz-Saenz J
Vet Microbiol; 2017 Mar; 201():56-61. PubMed ID: 28284623
[TBL] [Abstract][Full Text] [Related]
9. A survey of canine parvovirus-2 in Albania.
Kusi I
Dtsch Tierarztl Wochenschr; 1997 Nov; 104(11):478-80. PubMed ID: 9429323
[TBL] [Abstract][Full Text] [Related]
10. Detection of the Canine Parvovirus 2c Subtype in Australian Dogs.
Woolford L; Crocker P; Bobrowski H; Baker T; Hemmatzadeh F
Viral Immunol; 2017 Jun; 30(5):371-376. PubMed ID: 28414634
[TBL] [Abstract][Full Text] [Related]
11. Canine parvovirus in asymptomatic feline carriers.
Clegg SR; Coyne KP; Dawson S; Spibey N; Gaskell RM; Radford AD
Vet Microbiol; 2012 May; 157(1-2):78-85. PubMed ID: 22257775
[TBL] [Abstract][Full Text] [Related]
12. Clinical and inflammatory response to antiviral treatments in dogs with parvoviral enteritis.
Ulas N; Ozkanlar Y; Ozkanlar S; Timurkan MO; Aydin H
J Vet Sci; 2024 Jan; 25(1):e11. PubMed ID: 38311324
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant immunotherapy of feline fibrosarcoma with recombinant feline interferon-omega.
Hampel V; Schwarz B; Kempf C; Köstlin R; Schillinger U; Küchenhoff H; Fenske N; Brill T; Hirschberger J
J Vet Intern Med; 2007; 21(6):1340-6. PubMed ID: 18196745
[TBL] [Abstract][Full Text] [Related]
14. Limited efficacy of topical recombinant feline interferon-omega for treatment of cats with acute upper respiratory viral disease.
Ballin AC; Schulz B; Helps C; Sauter-Louis C; Mueller RS; Hartmann K
Vet J; 2014 Dec; 202(3):466-70. PubMed ID: 25457261
[TBL] [Abstract][Full Text] [Related]
15. Treatment of canine parvoviral enteritis with interferon-omega in a placebo-controlled field trial.
de Mari K; Maynard L; Eun HM; Lebreux B
Vet Rec; 2003 Jan; 152(4):105-8. PubMed ID: 12572939
[TBL] [Abstract][Full Text] [Related]
16. Early administration of canine parvovirus monoclonal antibody prevented mortality after experimental challenge.
Larson L; Miller L; Margiasso M; Piontkowski M; Tremblay D; Dykstra S; Miller J; Slagter BJ; Champ D; Keil D; Patel M; Wasmoen T
J Am Vet Med Assoc; 2024 Apr; 262(4):506-512. PubMed ID: 38295522
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of partial VP-2 gene amplified from rectal swab samples of diarrheic dogs in Pakistan confirms the circulation of canine parvovirus genetic variant CPV-2a and detects sequences of feline panleukopenia virus (FPV).
Ahmed N; Riaz A; Zubair Z; Saqib M; Ijaz S; Nawaz-Ul-Rehman MS; Al-Qahtani A; Mubin M
Virol J; 2018 Mar; 15(1):45. PubMed ID: 29544546
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the efficacy of the subcutaneous low recombinant feline interferon-omega administration protocol for feline chronic gingivitis-stomatitis in feline calicivirus-positive cats.
Matsumoto H; Teshima T; Iizuka Y; Sakusabe A; Takahashi D; Amimoto A; Koyama H
Res Vet Sci; 2018 Dec; 121():53-58. PubMed ID: 30359811
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of canine parvovirus enteritis: the importance of viremia.
Meunier PC; Cooper BJ; Appel MJ; Slauson DO
Vet Pathol; 1985 Jan; 22(1):60-71. PubMed ID: 2983478
[TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of a single dose of immune plasma for treatment of canine parvovirus infection.
Bragg RF; Duffy AL; DeCecco FA; Chung DK; Green MT; Veir JK; Dow SW
J Am Vet Med Assoc; 2012 Mar; 240(6):700-4. PubMed ID: 22380808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
